The FDA issued the 39th overall approval for Keytruda (pembrolizumab), with the latest in combination with chemoradiation for the treatment of patients with FIGO 2014 stage III to IVA cervical cancer.
Source link
#Merck039s #Keytruda #Receives #FDA #Approval #Cervical #Cancer
